Literature DB >> 2496083

Effects of CO2 breathing on ventilatory response to sustained hypoxia in normal adults.

D Georgopoulos1, D Berezanski, N R Anthonisen.   

Abstract

The relationship between CO2 and ventilatory response to sustained hypoxia was examined in nine normal young adults. At three different levels of end-tidal partial pressure of CO2 (PETCO2, approximately 35, 41.8, and 44.3 Torr), isocapnic hypoxia was induced for 25 min and after 7 min of breathing 21% O2, isocapnic hypoxia was reinduced for 5 min. Regardless of PETCO2 levels, the ventilatory response to sustained hypoxia was biphasic, characterized by an initial increase (acute hypoxic response, AHR), followed by a decline (hypoxic depression). The biphasic response pattern was due to alteration in tidal volume, which at all CO2 levels decreased significantly (P less than 0.05), without a significant change in breathing frequency. The magnitude of the hypoxic depression, independent of CO2, correlated significantly (r = 0.78, P less than 0.001) with the AHR, but not with the ventilatory response to CO2. The decline of minute ventilation was not significantly affected by PETCO2 [averaged 2.3 +/- 0.6, 3.8 +/- 1.3, and 4.5 +/- 2.2 (SE) 1/min for PETCO2 35, 41.8, and 44.3 Torr, respectively]. This decay was significant for PETCO2 35 and 41.8 Torr but not for 44.3 Torr. The second exposure to hypoxia failed to elicit the same AHR as the first exposure; at all CO2 levels the AHR was significantly greater (P less than 0.05) during the first hypoxic exposure than during the second. We conclude that hypoxia exhibits a long-lasting inhibitory effect on ventilation that is independent of CO2, at least in the range of PETCO2 studied, but is related to hypoxic ventilatory sensitivity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2496083     DOI: 10.1152/jappl.1989.66.3.1071

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  8 in total

1.  The hypoxic ventilatory response and ventilatory long-term facilitation are altered by time of day and repeated daily exposure to intermittent hypoxia.

Authors:  David G Gerst; Sanar S Yokhana; Laura M Carney; Dorothy S Lee; M Safwan Badr; Tabarak Qureshi; Magalie N Anthouard; Jason H Mateika
Journal:  J Appl Physiol (1985)       Date:  2010-08-19

2.  Modelling the dynamic ventilatory response to hypoxia in humans.

Authors:  D S Ward; A Dahan; C B Mann
Journal:  Ann Biomed Eng       Date:  1992       Impact factor: 3.934

3.  An automated pressure-swing absorption system to administer low oxygen therapy for persons with spinal cord injury.

Authors:  A Q Tan; J M Papadopoulos; A N Corsten; R D Trumbower
Journal:  Exp Neurol       Date:  2020-07-17       Impact factor: 5.330

4.  Impact of intermittent hypoxia on long-term facilitation of minute ventilation and heart rate variability in men and women: do sex differences exist?

Authors:  Harpreet Wadhwa; Ciprian Gradinaru; Gregory J Gates; M Safwan Badr; Jason H Mateika
Journal:  J Appl Physiol (1985)       Date:  2008-04-10

5.  The ventilatory response to CO2 of the peripheral and central chemoreflex loop before and after sustained hypoxia in man.

Authors:  A Berkenbosch; A Dahan; J DeGoede; I C Olievier
Journal:  J Physiol       Date:  1992-10       Impact factor: 5.182

6.  Thalamic mediation of hypoxic respiratory depression in lambs.

Authors:  Brian J Koos; Arezoo Rajaee; Basil Ibe; Catalina Guerra; Lawrence Kruger
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-01-27       Impact factor: 3.619

7.  Long-term facilitation of ventilation in humans with chronic spinal cord injury.

Authors:  Nicole J Tester; David D Fuller; Jason S Fromm; Martina R Spiess; Andrea L Behrman; Jason H Mateika
Journal:  Am J Respir Crit Care Med       Date:  2014-01-01       Impact factor: 21.405

Review 8.  The human ventilatory response to stress: rate or depth?

Authors:  Michael J Tipton; Abbi Harper; Julian F R Paton; Joseph T Costello
Journal:  J Physiol       Date:  2017-07-27       Impact factor: 5.182

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.